Saturday, April 24, 2010

Intraductal Papillary Mucinous Tumors of the Pancreas -- Conlon 23 (20): 4518 -- Journal of Clinical Oncology

Intraductal papillary mucinous neoplasms (IPMNs) have increasingly occupied the research attention of various medical disciplines because their broad-ranging malignant potential and imaging complexities can present management challenges. Given increasing use of imaging advances and a general heightened
awareness of IPMNs as a diagnostic entity, these tumors have garnered recognition as a promising subset of pancreatic tumors that can be well managed or cured. We review herein the characteristic imaging
Intraductal Papillary Mucinous Tumors of the Pancreas -- Conlon 23 (20): 4518 -- Journal of Clinical Oncology

SpringerLink - Journal Article

Thus, the prime prognostic factor in predicting the survival outcome of IPMNs is resectability, instead of resection itself. Long-term survival could also be expected in resectable IPMNs without resection. No resection for the IPMN may be justified for patients with high surgical risks, especially for those who are asymptomatic and very aged.


SpringerLink - Journal Article

Medline ® Abstracts for References 12-15 of 'Intraductal papillary mucinous neoplasm of the pancreas'

Medline ® Abstracts for References 12-15 of 'Intraductal papillary mucinous neoplasm of the pancreas'

Pancreatic Cancer: Pancreatica - FAQ

Pancreatic Cancer: Pancreatica - FAQ

Whipple: Details, Preparation & Recovery: BCM Dept of Surgery

Whipple: Details, Preparation & Recovery: BCM Dept of Surgery

Whipple: Details, Preparation & Recovery: BCM Dept of Surgery

Whipple: Details, Preparation & Recovery: BCM Dept of Surgery

All What to expect with Whipple Procedure messages

All What to expect with Whipple Procedure messages